Concomitant use of dupilumab with glucocorticoid in bullous pemphigoid reduces disease severity: A preliminary study

OBJECTIVE: To retrospectively analyze the efficacy and safety of dupilumab in the treatment of bullous pemphigoid. METHODS: From October 2020 to October 2022, the medical records of patients with bullous pemphigoid who were treated with dupilumab in our department were collected retrospectively to a...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Lingyu, Huang, Ruiting, Jiang, Fuqiong, You, Shuqiong, Wu, Qian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10367446/
https://www.ncbi.nlm.nih.gov/pubmed/37506153
http://dx.doi.org/10.1002/iid3.924

Ejemplares similares

Ejemplares similares